IFNG and neoplasm: To reduce toxicity, the association of cG250 fused with a dimeric form of TNFα was tested in a preclinical model of ccRCC, presenting low toxicity and significant antitumor response, with approximately 50% and 60% decrease in tumor size when used alone or in association with IFNγ, respectively [20].